Navigation Links
Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
Date:2/28/2008

SOUTH SAN FRANCISCO, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) announced today that Charles Butler, the company's senior director of investor relations, will present at the Susquehanna SIGnificant Options in Healthcare Conference at 10:00 a.m. ET / 7:00 a.m. PT on Tuesday, March 4, 2008.

The presentation will be webcast and may be accessed in the Event Calendar page under Investors on the Exelixis website at http://www.exelixis.com.

About Exelixis

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer. Currently, Exelixis' broad product pipeline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb Company, Genentech, Wyeth Pharmaceuticals and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com.


'/>"/>
SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
3. Exelixis Announces Closing of Public Offering of Common Stock
4. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
5. Exelixis Announces November 5 Webcast of its 2007 Third Quarter Financial Results Conference Call
6. Exelixis Announces Third Quarter 2007 Financial Results and Business Update
7. Exelixis Sells 80% Stake in Artemis to Taconic
8. Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
9. Exelixis Announces November 27 Webcast of Presentation at the 19th Annual Piper Jaffray Health Care Conference
10. Exelixis Announces November 28 Webcast of Presentation at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...care employment grew by 29,000 jobs in October, a...nt growth during the U.S. recession. However, clin... health systems are coming closer to having to act...istrators. , (Vocus) Nove...growing in October despite the shedding of jobs in...
(Date:11/24/2009)...-Asia/--NODPharmaceuticalsInc.announced,theUSPaten...cationfor,itsnano-particleoraldeliveryorNODtechnol...htoincorporatepeptidesor,proteinsintobio-adhesiven...administeredasinjections.NODtechnologyisaplatformt...ssuchasinsulin,interferon,growthhormone,exenatide...
(Date:11/24/2009)...-Asia/--ShanghaiBiolaxyannouncedthe,ChineseStateFo...stigationalnewdrugapplication(IND)foritsoralinsuli...treatdiabetes.ThisIND,approvalallowsBiolaxytoiniti...disordercharacteristicofhighbloodglucoseandpoor,me...veremicro-and,macro-vasculardiseases,lossofvision,...
(Date:11/24/2009)...recently approved the Promega PowerPlex 16 HS Syst...erating DNA records for the National DNA Index Sys...RWEB) -- The FBI recently approved the Promega Po... participating in, or generating DNA records for, ...ly contains more than seven million profiles and h...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...-for-10 split ratio, SEATTLE, Aug. 25 Cell Thera...ed that its Board of Directors has,authorized a 1-...rse split,will become effective as of August 31, 2... Lieu of Annual Meeting of,Shareholders held on Ju...uthorize the Board, in its discretion, to effect a...
... Eisai Corporation of,North America and its partn...U.S. Food and Drug Administration (FDA) has approv...n hydrochloride) for the prevention of,chemotherap...es 0.5 mg for,oral administration is indicated for...wing initial and repeat courses of moderately emet...
...2 Beckman,Coulter, Inc. (NYSE: BEC ), a leading ...that simplify, automate, and innovate complex biom...k, Beckman Coulter,s senior vice,president and chi...eisel,Healthcare Conference 2008 on Thursday, Sept...www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ), ...
Other Biology Technology:Cell Therapeutics, Inc. Announces Reverse Stock Split 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 3
(Date:11/25/2009)...ria don,t have easy lives. In addition to mammalia...natural enemies called bacteriophages, viruses tha... , Still, bacteria and another class of microorg... environments such as deep-sea volcanic vents) man...e a built-in defense system that helps protect the...
(Date:11/25/2009)... a lifetime, the heart pumps some 250 million lite...his, the muscle fibers of the heart have to be ext...olfgang Rottbauer, vice chair of the Department of...hairman: Prof. Dr. H. A. Katus), has discovered a ...he smallest muscular unit, the sarcomere. In coope...
(Date:11/24/2009)... Institute (LRI) today named 12 new grant recipien...cognize innovative work across a broad spectrum of...ivity, novelty, and potential to drive scientific ...he complex disease of systemic lupus. , The 2009...rchers across the nation and include interdiscipli...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 1 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 2 R E P E A T DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58843 3Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 1Cord Blood America Continues to Reduce Debt 3B Three Notes Retired 5207 2DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 1DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 2DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 58841 3
...d sizes, from grand Redwood trees to the common Sn...und plants rely on a complex network of roots. Wha... mystery, but a new paper published this week in ... root can determine how further roots branch from .... The work also suggests that the root-patterning ...
..., 2008 The elevated carbon dioxide levels expecte...ikely lead to physiological impairments of jumbo (...niversity of Rhode Island scientists., The result...or of biological sciences, and Rui Rosa, a former ...e University of Lisbon, Portugal, is reported in t...
... plumes of hot rock deep within the earth are link... researchers have found. , The two superplumes, ...ave likely existed for at least 200 million years,...rth sciences at Ohio State University. , The gian...- rise from the bottom of Earth,s mantle, just abo...
Other Biology News:Ocean acidification from CO2 emissions will cause physiological impairment to jumbo squid 2Ancient magma 'superpiles' may have shaped the continents 2Ancient magma 'superpiles' may have shaped the continents 3
Goat Anti-Human Factor VIII Polyclonal Antibody, Unconjugated from Abcam
Chicken Anti-Human Thioredoxin domain containing 9 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-L-isoleucine Antibody, Unconjugated from QED Bioscience Inc.
Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: